Representative · D-PA
Official title: To promote affordable access to evidence-based opioid treatments under the Medicare program and require coverage of medication assisted treatment for opioid use disorders, opioid overdose reversal medications, and recovery support services by health plans without cost-sharing requirements.
Introduced September 3, 2026 by Madeleine Dean · Last progress September 3, 2026